News

Angelini Industries announces the appointment of Jacopo Andreose as new Chief Executive Officer of Angelini Pharma, a pharmaceutical company active in brain health, including mental health and epilepsy, and consumer healthcare, which is part of the Angelini Industries, an Italian multi-business group.

If you’re a healthcare provider or oversee infection control at your facility, you’ve probably become aware of the EPA’s “N” List, which specifies registered disinfectants approved for use against SARS-CoV-2. However, you may have wondered how the list is developed, and how exactly to interpret its phrasing. We’re here to help.

Angelini Pharma and Arvelle Therapeutics have agreed on the 4th January 2021 a definitive merger agreement valuing Arvelle Therapeutics at up to $960 million.

On October 18th, a week devoted to celebrating the work of infection preventionists (IPs) begins worldwide. In these difficult times, IPs have been guiding the frontline healthcare workers — and often suiting up right alongside them — to slow the spread of COVID-19.